Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder

ClinicalTrials.gov ID: NCT00667745

Public ClinicalTrials.gov record NCT00667745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial

Study identification

NCT ID
NCT00667745
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
National Institute of Mental Health (NIMH)
NIH
Enrollment
283 participants

Conditions and interventions

Interventions

  • Lithium Carbonate Drug
  • Optimized Treatment (OPT) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Feb 12, 2018

2008 – 2010

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Stanford University Stanford California 94035-5723
Massachusetts General Hospital Boston Massachusetts 02114
Case Western Reserve University Cleveland Ohio 44106
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
University of Texas Health Science Center San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00667745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2018 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00667745 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →